Expanded Indication for 0.5mL Fluzone® Quadrivalent

The 0.5mL dose of Sanofi Pasteur’s Fluzone Quadrivalent vaccine has been newly approved to be used in children 6 months of age and older. This new option offers health care providers the simplicity of using the same 0.5mL dose for all eligible children when immunizing against the flu.  Fluzone Quadrivalent 0.25mL dose will still be available to order for children ages 6-35 months for the 2019-2020 season.

If you have already confirmed your 2019-2020 Sanofi Pasteur influenza vaccine reservation, you have the ability to adjust these quantities based on this new approval.

Contact your representative from Sanofi Pasteur or click here for more information.

New CPP Partnership with AstraZeneca!

CPP is pleased to announce a new partnership with AstraZeneca that provides our members a discount opportunity on doses of FluMist®, an intranasal influenza vaccine, for the upcoming 2019-2020 flu season.  Members who opt into this contract will receive a discount off the list price of doses ordered through an authorized distributor throughout the entire 2019-2020 flu season.  Authorized distributors of FluMist currently include McKesson Medical-Surgical Inc. and FFF Enterprises Inc.

To access this discount, please contact the CPP office at cpp@nationwidechildrens.org or 614-722-2145 to obtain pricing details, updated terms and conditions as well as a declaration form.  If you participated in the FluMist discount in prior flu seasons under CPP-MedImmune contract, we will still need an updated declaration form to show your acceptance of the new agreement under AstraZeneca.

Members who are interested in pre-booking FluMist doses should place their reservations with an authorized distributor prior to March 31, 2019.

We hope this will be of interest to your practice as we are always trying to find ways to provide more value to our members!